82 related articles for article (PubMed ID: 12646513)
1. No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.
Lancaster JM; Wenham RM; Halabi S; Calingaert B; Marks JR; Moorman PG; Bentley RC; Berchuck A; Schildkraut JM
Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):226-7. PubMed ID: 12646513
[No Abstract] [Full Text] [Related]
2. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.
Spillman MA; Schildkraut JM; Halabi S; Moorman P; Calingaert B; Bentley RC; Marks JR; Murphy S; Berchuck A
Gynecol Oncol; 2005 May; 97(2):543-9. PubMed ID: 15863158
[TBL] [Abstract][Full Text] [Related]
4. PGR +331 A/G and increased risk of epithelial ovarian cancer.
Risch HA; Bale AE; Beck PA; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1738-41. PubMed ID: 16985038
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer.
Leite DB; Junqueira MG; de Carvalho CV; Massad-Costa AM; Gonçalves WJ; Nicolau SM; Lopes LA; Baracat EC; da Silva ID
Steroids; 2008 Jul; 73(6):676-80. PubMed ID: 18384825
[TBL] [Abstract][Full Text] [Related]
7. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
[TBL] [Abstract][Full Text] [Related]
8. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
[TBL] [Abstract][Full Text] [Related]
9. No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.
Feigelson HS; Rodriguez C; Jacobs EJ; Diver WR; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1084-5. PubMed ID: 15184270
[No Abstract] [Full Text] [Related]
10. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
11. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
De Vivo I; Hankinson SE; Colditz GA; Hunter DJ
Cancer Res; 2003 Sep; 63(17):5236-8. PubMed ID: 14500352
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer.
Sehouli J; Mustea A; Koensgen D; Lichtenegger W
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1205-8. PubMed ID: 14652282
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer.
Bushley AW; Ferrell R; McDuffie K; Terada KY; Carney ME; Thompson PJ; Wilkens LR; Tung KH; Ness RB; Goodman MT
Gynecol Oncol; 2004 Dec; 95(3):672-9. PubMed ID: 15581980
[TBL] [Abstract][Full Text] [Related]
14. Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?
Lattuada D; Somigliana E; Viganò P; Candiani M; Pardi G; Di Blasio AM
Clin Endocrinol (Oxf); 2004 Aug; 61(2):190-4. PubMed ID: 15272913
[TBL] [Abstract][Full Text] [Related]
15. Estrogen bioactivation, genetic polymorphisms, and ovarian cancer.
Sellers TA; Schildkraut JM; Pankratz VS; Vierkant RA; Fredericksen ZS; Olson JE; Cunningham J; Taylor W; Liebow M; McPherson C; Hartmann LC; Pal T; Adjei AA
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2536-43. PubMed ID: 16284375
[TBL] [Abstract][Full Text] [Related]
16. The N314D polymorphism of galactose-1-phosphate uridyl transferase does not modify the risk of ovarian cancer.
Fung WL; Risch H; McLaughlin J; Rosen B; Cole D; Vesprini D; Narod SA
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):678-80. PubMed ID: 12869412
[TBL] [Abstract][Full Text] [Related]
17. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study.
Jo H; Kang S; Kim SI; Kim JW; Park NH; Song YS; Park SY; Kang SB; Lee HP
Gynecol Obstet Invest; 2007; 64(2):84-8. PubMed ID: 17314486
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
20. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.
Schildkraut JM; Moorman PG; Bland AE; Halabi S; Calingaert B; Whitaker R; Lee PS; Elkins-Williams T; Bentley RC; Marks JR; Berchuck A
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):585-93. PubMed ID: 18349276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
